- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Breast Tumour in United Kingdom
Total 15619 results
-
LondonPharma Ltd.UnknownSolid TumoursUnited Kingdom
-
AstraZenecaCompletedHER2-negative Breast CancerMexico, United Kingdom, Georgia
-
Northwestern UniversityNational Cancer Institute (NCI); AmgenTerminatedStage IV Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Breast Carcinoma Metastatic in the Bone | Circulating Tumor Cell CountUnited States
-
PfizerCompletedHR+/HER2- Locally Advanced, Metastatic Breast CancerUnited Kingdom
-
Nippon Kayaku Co., Ltd.CompletedAdvanced Solid Tumors | Metastatic Triple Negative Breast CancerUnited States
-
AstraZenecaTerminated
-
University of OxfordNational Institute for Health Research, United KingdomEnrolling by invitationBreast Cancer | Risk ReductionUnited Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompleted
-
East and North Hertfordshire NHS TrustUniversity of Exeter; Mount Vernon Cancer Centre at Mount Vernon Hospital; International... and other collaboratorsCompletedBreast Cancer | Head and Neck Cancer | LymphedemaUnited Kingdom
-
Royal Marsden NHS Foundation TrustRecruitingSolid Tumor, AdultUnited Kingdom
-
The Leeds Teaching Hospitals NHS TrustUnknownBreast CancerUnited Kingdom
-
South Tees Hospitals NHS Foundation TrustNewcastle University; Newcastle-upon-Tyne Hospitals NHS Trust; University of...CompletedBreast Cancer | Non Hodgkin LymphomaUnited Kingdom
-
Boehringer IngelheimCompleted
-
Cancer Research UKUCB Biopharma SRLNot yet recruitingUterine Cervical Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Pancreatic Neoplasms | Esophageal Neoplasms | Ovarian Neoplasms | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Neoplasms | Advanced Solid Tumours | Carcinoma, Renal Cell (Clear Cell Only) | Stomach Neoplasms...United Kingdom
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; Integra LifeSciences CorporationUnknownBreast Neoplasms | Breast DiseasesUnited Kingdom
-
Bristol-Myers SquibbCompleted
-
Orinove, Inc.Active, not recruitingMetastatic Breast Cancer | Advanced Solid TumorUnited States
-
Scottish Cancer Therapy NetworkCompletedBreast CancerUnited Kingdom
-
Scottish Cancer Therapy NetworkCompletedBreast CancerUnited Kingdom
-
Scottish Cancer Therapy NetworkCompleted
-
NBE-Therapeutics AGCmed Clinical ServicesTerminatedTriple Negative Breast Cancer | Advanced Solid Tumor | Advanced CancerUnited States
-
Nuvation Bio Inc.TerminatedGlioma | Breast Cancer | Glioblastoma | Advanced Breast Cancer | Prostate Cancer | Metastatic Breast Cancer | Recurrent Glioblastoma | Breast Carcinoma | Castration-resistant Prostate Cancer | Prostate Neoplasm | Cancer of the Prostate | Prostatic Cancer | Glioma, Malignant | Cancer of Breast | Malignant Tumor of Breast and other conditionsUnited States
-
TransThera Sciences (Nanjing), Inc.Active, not recruitingAdvanced Solid Tumors | Triple Negative Breast CancerUnited States, China
-
Royal Marsden NHS Foundation TrustNational Institute for Health Research, United KingdomCompletedBone Metastases | Brain Metastases | Brain Tumor, Primary | Brain Tumor Adult | Brain Tumor - MetastaticUnited Kingdom
-
AstraZenecaCompletedAdvanced Solid Malignancies | Breast Cancer - ER+, HER2 - | Breast Cancer - ER+, HER2-, PIK3CA Gene MutationUnited States, United Kingdom
-
Mayo ClinicCompletedBreast Cancer | Dense BreastsUnited States
-
Mayo ClinicCompleted
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | Breast Neoplasm | Carcinoma, Ductal, BreastUnited Kingdom, Bulgaria, Georgia, Moldova, Republic of
-
BioInvent International ABActive, not recruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | HER2-positive Metastatic Breast CancerSpain, United Kingdom, Germany
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | HER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Imperial College LondonRecruitingBreast Cancer | Mobility LimitationUnited Kingdom
-
NantCell, Inc.CompletedBreast Cancer | Metastatic Cancer | Breast TumorsUnited States, France, Canada, United Kingdom, Spain, Australia, Germany, Ireland, Switzerland
-
Novartis PharmaceuticalsCompletedLymphoma | Breast Cancer | Lung Cancer | Brain and Central Nervous System Tumors | Melanoma (Skin) | Islet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic SyndromeUnited States
-
University of GlasgowUnknown
-
Birmingham City UniversityCompletedBody Temperature Changes | Breast FeedingUnited Kingdom
-
Institute of Cancer Research, United KingdomHoffmann-La RocheRecruitingSolid Tumor | Glioblastoma Multiforme | Prostate Cancer MetastaticUnited Kingdom
-
NHS TaysideUniversity of DundeeCompleted
-
Oxford University Hospitals NHS TrustTerminated
-
AstraZenecaCompletedSafety and Tolerability, | Advanced Solid Malignancy, | Pharmacokinetics, Pharmacodynamics, | Tumour Response,United Kingdom, Netherlands
-
University Hospitals Bristol and Weston NHS Foundation...RecruitingHER2 Negative Metastatic Breast CancerUnited Kingdom
-
Cancer Research UKTerminatedAdvanced Solid TumoursUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustUnknownBreast Cancer | Perioperative/Postoperative Complications | Cardiac ToxicityUnited Kingdom
-
Royal Marsden NHS Foundation TrustUnknownMastalgia | Breast PainUnited Kingdom
-
Royal Marsden NHS Foundation TrustPfizer; Hoffmann-La RocheRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | ER+ Breast CancerUnited Kingdom
-
Washington University School of MedicineCompletedMelanoma | Breast Cancer | Malignant Melanoma | Cancer of Breast | Cancer of the BreastUnited States
-
Blueprint Medicines CorporationRecruitingGastric Cancer | Ovarian Cancer | Carcinosarcoma | Advanced Solid Tumors | Endometrial Cancer | Esophageal Adenocarcinoma | HER2-negative Breast Cancer | CCNE1 Amplification | HR+ Breast CancerUnited States, Italy, United Kingdom
-
Eisai Inc.CompletedBreast Cancer | Estrogen Receptor Positive TumorUnited States
-
Hoffmann-La RocheCompleted
-
Treadwell Therapeutics, IncRecruitingBreast Cancer | Advanced Solid TumorUnited States
-
AstraZenecaCompletedPostmenopausal Women With ER+ HER2- Primary Breast CancerGermany, United Kingdom